Preventive drugs in the last year of life of older adults with cancer: Is there room for deprescribing?
Fiche publication
Date publication
juillet 2019
Journal
Cancer
Auteurs
Membres identifiés du Cancéropôle Est :
Dr MORIN Lucas
Tous les auteurs :
Morin L, Todd A, Barclay S, Wastesson JW, Fastbom J, Johnell K
Lien Pubmed
Résumé
The continuation of preventive drugs among older patients with advanced cancer has come under scrutiny because these drugs are unlikely to achieve their clinical benefit during the patients' remaining lifespan.
Mots clés
deprescribing, drug prescribing, end of life, palliative care
Référence
Cancer. 2019 07 1;125(13):2309-2317